A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator’s choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
Titel:
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator’s choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
Auteur:
Kiyota, Naomi Hasegawa, Yasuhisa Takahashi, Shunji Yokota, Tomoya Yen, Chia-Jui Iwae, Shigemichi Shimizu, Yasushi Hong, Ruey-Long Goto, Masahiro Kang, Jin-Hyoung Sum Kenneth Li, Wing Ferris, Robert L. Gillison, Maura Namba, Yoshinobu Monga, Manish Lynch, Mark Tahara, Makoto